• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于原发性乳腺癌组织切片中雌激素受体状态免疫组织化学检测的单克隆抗体

[Monoclonal antibodies for the immunohistochemical detection of estrogen receptor status in tissue sections of primary breast cancers].

作者信息

Beck T, Pollow K, Heubner A

出版信息

Geburtshilfe Frauenheilkd. 1986 Aug;46(8):490-4. doi: 10.1055/s-2008-1036243.

DOI:10.1055/s-2008-1036243
PMID:3530871
Abstract

The article reports on first experiences with immunohistochemical staining methods (ER-ICA and ER-D5) using monoclonal antibodies for determination of oestrogen receptor status in tissue slides. 95 primary breast cancers were analysed by ER-ICA; in addition, a subgroup of 31 cases was stained for ER-D5. The results of the two immunohistochemical procedures revealed a large measure of agreement with the standard ligand binding assay. The evaluation of the immunohistochemical staining reaction led to the formation of a staining Score: Score points of ER-ICA, not those of ER-D5, revealed good correlation with oestrogen receptor concentrations in cytosol, determined by standard ligand binding assay. The used staining Score was examined for intra- and inter-individual differences of evaluation and proved to be well reproducible. Further clinical studies have to prove how far immunohistochemical features can convey clinically relevant information not yielded by the steroid binding assay.

摘要

本文报道了使用单克隆抗体的免疫组织化学染色方法(ER-ICA和ER-D5)在组织切片中测定雌激素受体状态的首次经验。通过ER-ICA分析了95例原发性乳腺癌;此外,对31例病例的亚组进行了ER-D5染色。两种免疫组织化学方法的结果显示与标准配体结合试验有很大程度的一致性。免疫组织化学染色反应的评估导致了染色评分的形成:ER-ICA的评分点,而非ER-D5的评分点,与通过标准配体结合试验测定的细胞溶质中雌激素受体浓度显示出良好的相关性。对所使用的染色评分进行了个体内和个体间评估差异的检查,结果证明其具有良好的可重复性。进一步的临床研究必须证明免疫组织化学特征在多大程度上能够传达类固醇结合试验未提供的临床相关信息。

相似文献

1
[Monoclonal antibodies for the immunohistochemical detection of estrogen receptor status in tissue sections of primary breast cancers].用于原发性乳腺癌组织切片中雌激素受体状态免疫组织化学检测的单克隆抗体
Geburtshilfe Frauenheilkd. 1986 Aug;46(8):490-4. doi: 10.1055/s-2008-1036243.
2
Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer.雌激素受体、表皮生长因子受体、ER-D5和P24雌激素调节蛋白在人类乳腺癌中的关系。
J Pathol. 1988 Jun;155(2):143-50. doi: 10.1002/path.1711550211.
3
Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.雌激素受体免疫细胞化学检测(ER-ICA):计算机图像分析系统、免疫电子显微镜以及与115例乳腺癌中雌二醇结合检测的比较
Cancer Res. 1986 Aug;46(8 Suppl):4271s-4277s.
4
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.使用新型兔单克隆抗体SP1对乳腺癌雌激素受体进行免疫组织化学检测,在预测生存率方面优于小鼠单克隆抗体1D5。
J Clin Oncol. 2006 Dec 20;24(36):5637-44. doi: 10.1200/JCO.2005.05.4155. Epub 2006 Nov 20.
5
Evaluation of estrogen receptor immunocytochemical assay (ER-ICA) and estrogen receptor enzyme immunoassay (ER-EIA) for the determination of estrogen receptor status in breast carcinoma. A comparative study on frozen sections, cytological smears and tissue homogenates.评估雌激素受体免疫细胞化学检测法(ER-ICA)和雌激素受体酶免疫分析法(ER-EIA)用于确定乳腺癌中雌激素受体状态。对冰冻切片、细胞学涂片和组织匀浆的比较研究。
Patol Pol. 1991;42(1):17-23.
6
Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).乳腺癌中激素受体的免疫组织化学检测(ER-ICA、PgR-ICA):预后价值及与生化放射性配体结合测定法(DCC)的比较
Gynecol Oncol. 1994 May;53(2):220-7. doi: 10.1006/gyno.1994.1119.
7
Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.通过免疫细胞化学法评估乳腺癌中的孕激素受体(PR)和雌激素受体(ER)。与放射性配体结合法的比较。
Am J Clin Pathol. 1990 Oct;94(4 Suppl 1):S35-40.
8
[Estrogen receptor status in breast carcinoma. Results of comparative immunohistochemical and biochemical studies].[乳腺癌中的雌激素受体状态。免疫组织化学和生物化学对比研究结果]
Dtsch Med Wochenschr. 1986 Dec 19;111(51-52):1954-60. doi: 10.1055/s-2008-1068742.
9
[Immunohistochemical determination of estrogen receptors in breast carcinoma tissue using monoclonal antibodies. 1st clinical findings].[使用单克隆抗体对乳腺癌组织中雌激素受体进行免疫组织化学测定。首次临床研究结果]
Geburtshilfe Frauenheilkd. 1985 Jul;45(7):473-6. doi: 10.1055/s-2008-1036355.
10
[An immunohistochemical investigation of estrogen receptor in human breast cancer].
Gan No Rinsho. 1990 Feb;36(2):143-7.

引用本文的文献

1
Immunohistochemical study of distribution of estrogen receptors in corpus and cervix uteri.雌激素受体在子宫体和子宫颈中分布的免疫组织化学研究。
Arch Gynecol Obstet. 1988;241(4):221-33. doi: 10.1007/BF00931353.
2
Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody.使用单克隆抗体对福尔马林固定石蜡包埋的乳腺癌组织中的孕激素受体进行免疫组织化学检测。
Arch Gynecol Obstet. 1990;247(2):63-71. doi: 10.1007/BF02390663.